<code id='A3958CD346'></code><style id='A3958CD346'></style>
    • <acronym id='A3958CD346'></acronym>
      <center id='A3958CD346'><center id='A3958CD346'><tfoot id='A3958CD346'></tfoot></center><abbr id='A3958CD346'><dir id='A3958CD346'><tfoot id='A3958CD346'></tfoot><noframes id='A3958CD346'>

    • <optgroup id='A3958CD346'><strike id='A3958CD346'><sup id='A3958CD346'></sup></strike><code id='A3958CD346'></code></optgroup>
        1. <b id='A3958CD346'><label id='A3958CD346'><select id='A3958CD346'><dt id='A3958CD346'><span id='A3958CD346'></span></dt></select></label></b><u id='A3958CD346'></u>
          <i id='A3958CD346'><strike id='A3958CD346'><tt id='A3958CD346'><pre id='A3958CD346'></pre></tt></strike></i>

          entertainment

          entertainment

          author:focus    Page View:9
          David Sabatini
          Wikimedia Commons

          Former MIT and Whitehead Institute star biologist David Sabatini, who lost his positions after he was accused of violating sexual harassment policies in 2021, is resuming his science career, taking a post at a Czech research institute in Prague.

          Sabatini, of Cambridge, confirmed in a phone call from Prague that he has accepted a position as a “senior group leader” at the Institute of Organic Chemistry and Biochemistry, known as IOCB Prague. Sabatini said he will be recruiting staff and running a laboratory in the Czech Republic capital to investigate scientific questions in the areas of cell growth and metabolism, similar to his past research in Cambridge.

          advertisement

          “I’m very grateful to be given the opportunity to do science again,” said Sabatini, who began working at the institute last month.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          Supreme Court strikes down use of affirmative action
          Supreme Court strikes down use of affirmative action

          ActivistsdemonstratedastheSupremeCourtheardoralargumentsonapairofaffirmativeactioncasesinOctober2022

          read more
          J&J expands global access to TB drug amid advocacy campaign
          J&J expands global access to TB drug amid advocacy campaign

          ChrisO'Meara/APAdvocateshavebeenfightingJohnson&Johnsonforyearsoverapatentonalifesavingtube

          read more
          Medicare proposal to cover medical devices draws a mixed reaction
          Medicare proposal to cover medical devices draws a mixed reaction

          AdobeThemedicaldeviceindustryissplitonwhetheraproposednewMedicarereimbursementpathwaywilldoanythingt

          read more

          Eli Lilly to acquire Versanis in heated race for weight loss drugs

          DarronCummings/APEliLillysaidFridayitwillacquireVersanisBio,aprivatecompanydevelopinganobesitydrugth